… and bleeding events in dabigatran-treated patients may be of … the association between
bleeding events and coagulation … risk factors for bleeding in Chinese NVAF patients receiving …

… incidence of bleeding events among patients with NVAF enrolled … of bleeding events of
various severities among patients with … (NVAF) enrolled in managed care, to determine bleeding …

… in patients who have nonvalvular atrial fibrillation (NVAF). As … event with rivaroxaban in the
registration trial was bleeding. … Major bleeding events were included in this analysis if they …

… we identified incident NVAF patients without history of stroke or bleeding. Patients were
followed from … This study builds on previous work estimating event costs in NVAF patients [30] by …

… about the bleeding events associated with the use of NOACs among NVAF patients in real-…
the risk of major bleeding among newly anticoagulated NVAF patients initiating warfarin vs …

… or similar risk of major bleeding compared with warfarin in NVAF patients. Apixaban was …
in NVAF. It’s been shown that the absolute rates of major bleeding events in AF patients …

… In conclusion, concurrent aspirin use is common in racially diverse NVAF patient population
on rivaroxaban in the community setting. Increasing age and concurrent aspirin use are …

… Therefore, the aim of this study was to investigate the relationship between serum vit E/chol
concentration and bleeding events in NVAF patients given OAT, and the clinical variables …

… This study was an assessment of the bleeding events and the APTT values with
dabigatran among NVAF patients in clinical practice. The APTT values were prolonged under …

… NVAF patients with prior bleed history are lacking. This study included data on OAC-treated
NVAF patients with a history of bleeding… of 244,563 NVAF patients with prior bleeding events …